Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Department of Surgery, Ajou University School of Medicine, Suwon, Korea.
J Gastric Cancer. 2024 Oct;24(4):356-366. doi: 10.5230/jgc.2024.24.e35.
The usability of a new surgical navigation system that provides patient-specific vascular information for robotic gastrectomy in gastric cancer remains unexplored for laparoscopic gastrectomy owing to differences in surgical environments. This study aimed to evaluate the applicability and safety of this navigation system in laparoscopic gastrectomy and to compare the post-operative outcomes between procedures with and without its use.
Between June 2022 and July 2023, 38 patients across 2 institutions underwent laparoscopic gastrectomy using a navigation system (navigation group). The technical feasibility, safety, and accuracy of detecting variations in vascular anatomy were measured. The perioperative outcomes were compared with 114 patients who underwent laparoscopic gastrectomy without a navigation system (non-navigation group) using 1:3 propensity score matching during the same study period.
In all patients in the navigation group, no adverse events associated with the navigation system occurred during surgery in any patient in the navigation group. No accidental vessel injuries necessitate auxiliary procedures. All vessels encountered during the gastrectomy were successfully reconstructed and visualized. Patient demographics and operative data were comparable between the 2 groups. The navigation group exhibited a significantly lower overall complication rate (10.5%) than the non-navigation group (26.3%, P=0.043). Notably, pancreas-related complications were absent in the navigation group but occurred in eight cases in the non-navigation group (7.0%, P=0.093), although the difference was not statistically significant.
The patient-specific surgical navigation system demonstrated clinical feasibility and safety for laparoscopic gastrectomy for gastric cancer, potentially reducing complication rates compared with laparoscopic gastrectomy without its use.
由于手术环境的差异,新的手术导航系统在腹腔镜胃癌手术中为机器人胃癌手术提供患者特定的血管信息的可用性尚未在腹腔镜胃切除术中得到探索。本研究旨在评估该导航系统在腹腔镜胃切除术中的适用性和安全性,并比较使用和不使用该导航系统的手术的术后结果。
在 2022 年 6 月至 2023 年 7 月期间,2 家机构的 38 名患者接受了导航系统辅助的腹腔镜胃切除术(导航组)。测量了检测血管解剖结构变化的技术可行性、安全性和准确性。使用同一研究期间的 1:3 倾向评分匹配,将手术期间使用和不使用导航系统的 114 名患者(非导航组)的围手术期结果进行了比较。
在导航组的所有患者中,在任何患者中,导航系统在手术期间均未发生与导航系统相关的不良事件。没有发生意外的血管损伤需要辅助手术。在胃切除术中遇到的所有血管均成功重建和可视化。两组患者的人口统计学和手术数据无差异。导航组的总并发症发生率(10.5%)明显低于非导航组(26.3%,P=0.043)。值得注意的是,导航组没有胰腺相关并发症,而非导航组有 8 例(7.0%,P=0.093),尽管差异无统计学意义。
针对胃癌的腹腔镜胃切除术的患者特异性手术导航系统具有临床可行性和安全性,与不使用腹腔镜胃切除术相比,可能降低并发症发生率。